World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
38
Citations
7389
World Ranking
8496
National Ranking
3618

Overview

Pavel V. Belichenko is a researcher affiliated with the University of California, San Diego in the United States. Their academic work primarily focuses on the field of Medicine, with research contributions across several related subfields.

The main areas of study for Belichenko include Public Health, Environmental and Occupational Health, Psychiatry and Mental Health, and Endocrinology, Diabetes and Metabolism. Their research topics cover the following domains:

  • Down syndrome and intellectual disability research
  • Cerebral Palsy and Movement Disorders
  • Diabetes Management and Research

Belichenko's publication record includes work in the journal PLoS ONE. Specifically, they have authored a paper titled "Correction: An Anti-β-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome", published in 2025 in PLoS ONE.

The researcher has collaborated with frequent co-authors, including:

  • Rime Madani
  • Lorianne Rey-Bellet
  • Maria Pihlgren
  • Ann Becker
  • Adeline Plassard

This collaboration suggests interdisciplinary work that likely integrates perspectives relevant to their main topics of study.

Belichenko's research contributes to understanding disorders related to intellectual disability, neurodegenerative conditions, and metabolic diseases, with implications for treatment and management strategies.

Best Publications

  • Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.

    Alexander M. Kleschevnikov;Pavel V. Belichenko;Angela J. Villar;Charles J. Epstein

  • Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

    Ahmad Salehi;Jean Dominique Delcroix;Pavel V. Belichenko;Ke Zhan

  • Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.

    Jonathan D. Cooper;Ahmad Salehi;Jean-Dominique Delcroix;Charles L. Howe

  • Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.

    Pavel V. Belichenko;Eliezer Masliah;Alexander M. Kleschevnikov;Angela J. Villar

  • Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.

    Pavel V. Belichenko;Elena E. Wright;Nadia P. Belichenko;Eliezer Masliah

  • Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain.

    Barbro B Johansson;Pavel V Belichenko

  • Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents.

    Pavel V. Belichenko;Anders Oldfors;Bengt Hagberg;Annica Dahlström

  • Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.

    Pavel V. Belichenko;Alexander M. Kleschevnikov;Ahmad Salehi;Charles J. Epstein

  • Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.

    E. Kakkis;E. Kakkis;M. McEntee;C. Vogler;S. Le

  • The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.

    Nadia P. Belichenko;Pavel V. Belichenko;Alexander M. Kleschevnikov;Ahmad Salehi

  • Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists

    Alexander M. Kleschevnikov;Pavel V. Belichenko;Mehrdad Faizi;Lucia F. Jacobs

  • Morphological study of neocortical areas in Rett syndrome

    Pavel V. Belichenko;Bengt Hagberg;A. Dahlström

  • Guidelines for reporting clinical features in cases with MECP2 mutations

    Alison M. Kerr;Yoshiko Nomura;Dawna Armstrong;Maria Anvret

  • Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.

    Pavel V. Belichenko;Alexander M. Kleschevnikov;Eliezer Masliah;Chengbiao Wu

  • Neuroprotection of Host Cells by Human Central Nervous System Stem Cells in a Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis

    Stanley J. Tamaki;Yakop Jacobs;Monika Dohse;Alexandra Capela

  • Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

    Mehrdad Faizi;Patrick L. Bader;Christine Tun;Angelo Encarnacion

  • Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.

    G Watson;J Bastacky;P Belichenko;M Buddhikot

  • Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice

    Tao Yu;Chunhong Liu;Pavel Belichenko;Steven J. Clapcote

  • Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

    Alexander M. Kleschevnikov;Pavel V. Belichenko;Pavel V. Belichenko;Jessica Gall;Lizzy George

  • Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouseChromosome 12

    Angela J. Villar;Pavel V. Belichenko;Anne Marie Gillespie;Heather M. Kozy

  • Studies on the 3-dimensional architecture of dendritic spines and varicosities in human cortex by confocal laser scanning microscopy and Lucifer yellow microinjections.

    Pavel V. Belichenko;Annica Dahlström

Frequent Co-Authors

William C. Mobley
William C. Mobley University of California, San Diego
Ahmad Salehi
Ahmad Salehi Stanford University
Eliezer Masliah
Eliezer Masliah National Institutes of Health
Uta Francke
Uta Francke Stanford University
Antonio Baldini
Antonio Baldini University of Naples Federico II
Mehrdad Shamloo
Mehrdad Shamloo Stanford University
Elizabeth M. C. Fisher
Elizabeth M. C. Fisher University College London
Robert C. Malenka
Robert C. Malenka Stanford University
Stylianos E. Antonarakis
Stylianos E. Antonarakis University of Geneva
John Christodoulou
John Christodoulou University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience opens doors to a wide range of related online degrees and career options in mental health and social services. Many students expand their skillset with advanced credentials in therapy, psychology, or social work, which can complement neuroscience expertise.

For those interested in counseling, several online mft programs accredited by respected bodies offer the chance to become licensed Marriage and Family Therapists. Others consider pursuing an affordable online masters in clinical psychology to deepen their understanding of psychological disorders and assessment.

Bachelor’s-level options such as an online psychology degree can provide foundational knowledge for neuroscience graduates interested in human behavior and research. Additionally, neuroscience backgrounds are valuable for those seeking an online master's in social work, preparing graduates for influential roles in mental health, healthcare, and community support.

Exploring these related degrees can help neuroscience students diversify their career pathways and adapt to the evolving demands of the behavioral health and social sciences fields.

Best Scientists Citing Pavel V. Belichenko

Recently Published Articles